Role of proliferative markers in breast lesions

被引:1
|
作者
Manna, Asim Kumar [1 ]
Pathak, Swapan [1 ]
Sarkar, Diptendra Kumar [2 ]
机构
[1] IPGME&R, Dept Pathol, Kolkata, India
[2] IPGME&R, Dept Surg, Kolkata, India
关键词
Breast lesions; Proliferative markers; DUCTAL CARCINOMA;
D O I
10.1007/s12262-010-0010-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Carcinoma of breast is a leading cause of death in women throughout the world. Difficulty in diagnosis occurs in routine Hematoxylin and Eosin (H&E) stained sections to differentiate premalignant lesions like epitheliosis and malignant lesions like carcinoma in situ which may affect prognosis. Our study was done to assess the role of proliferative markers in this field. In this study, total 66 cases of different breast lesions were studied by H&E stained sections as well as proliferative markers like silver staining nucleolar organizer region (AgNOR) and proliferating cell nuclear antigen (PCNA). Statistically significant differences found in expression of proliferative markers between most of them. Study of proliferative markers help in the proper diagnosis of different breast lesions which lies in the grey zone on routine histopathology.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 50 条
  • [41] Intranuclear inclusions in epithelial cells of benign proliferative breast lesions
    Harada, Oi
    Hoe, Rebecca
    Lin, Jieyan
    Thike, Aye Aye
    Jara-Lazaro, Ana Richelia
    Petersson, Fredrik
    Tan, Puay Hoon
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (09) : 776 - 780
  • [42] A DILUTIONAL IMMUNOPEROXIDASE STUDY OF PROLIFERATIVE DUCTAL LESIONS AND CARCINOMATA OF THE BREAST
    WELLS, S
    HASLETON, PS
    HISTOPATHOLOGY, 1981, 5 (05) : 517 - 526
  • [43] Quality of life is adversely affected by the diagnosis of proliferative breast lesions
    Albright, Emily
    Sugg, Sonia
    Erdahl, Lillian
    Weigel, Ronald
    Lizarraga, Ingrid
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 58 - 59
  • [44] Telomerase activity (TA) is not a marker of malignancy in proliferative breast lesions
    Poremba, C
    Willenbring, H
    Schafer, KL
    Diallo, R
    Otterbach, F
    Dockhorn-Dworniczak, B
    Bocker, W
    MODERN PATHOLOGY, 1998, 11 (01) : 25A - 25A
  • [45] Expression of biological markers in the apocrine lesions of breast
    Yoon, H. K.
    An, H. J.
    Jung, S. J.
    HISTOPATHOLOGY, 2012, 61 : 33 - 34
  • [46] LOW DOSE TAMOXIFEN AS TREATMENT OF BENIGN BREAST PROLIFERATIVE LESIONS
    Balalau, Cristian
    Voiculescu, Stefan
    Motofei, Ion
    Scaunasu, Razvan Valentin
    Negrei, Carolina
    FARMACIA, 2015, 63 (03) : 371 - 375
  • [47] Intraductal Proliferative Lesions of the Breast-Terminology and BiologyMatter: Premalignant Lesions or Preinvasive Cancer?
    Costarelli, Leopoldo
    Campagna, Domenico
    Mauri, Maria
    Fortunato, Lucio
    INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2012, 2012
  • [48] Proliferative and other lesions of the male breast - With notes on 2 cases of proliferative mastitis in stilbcestrol workers
    Scarff, RW
    Smith, CP
    BRITISH JOURNAL OF SURGERY, 1942, 29 (116) : 393 - 396
  • [49] The Role of Sonoelastography in Breast Lesions
    Barr, Richard G.
    SEMINARS IN ULTRASOUND CT AND MRI, 2018, 39 (01) : 98 - 105